Expedited review of new drugs - Reply

JAMA

Volumn 309, Issue 3, 2013, Pages 237-

  Moore, Thomas J ^a   Furberg, Curt D ^b  

^a INSTITUTE FOR SAFE MEDICATION PRACTICES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG LABELING; DRUG MARKETING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; LETTER; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES; HUMAN; NOTE; ORGANIZATION AND MANAGEMENT; PATIENT SAFETY;

DRUG APPROVAL; EFFICIENCY, ORGANIZATIONAL; HUMANS; PATIENT SAFETY; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84872469313     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.56920     Document Type: Letter

References (1)

1. Moore TJ, Singh S, Furberg CD. The FDA and new safety warnings. Arch Intern Med. 2012;172(1):78-80.